WHO recommends two new drugs to treat patients with COVID-19
The first drug, baricitinib, is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis. According to the WHO Guideline Development Group, it is “strongly recommended” for patients with severe or critical disease in combination with corticosteroids. The group of international experts based their recommendation on “moderate certainty evidence” that it improves survival and reduces the need for…
Read More
